Reduction of transendothelial migration of mononuclear cells in interferon-β1b-treated multiple sclerosis patients

被引：0
|
作者：
Corsini, E [1 ]
Gelati, M [1 ]
Dufour, A [1 ]
Ciusani, E [1 ]
La Mantia, L [1 ]
Massa, G [1 ]
Milanese, C [1 ]
Salmaggi, A [1 ]
机构：
[1] Ist Nazl Neurol Carlo Besta, Milan, Italy
来源：
ANNALS OF NEUROLOGY | 1999年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [21] Interferon-β-1b -: In newly emerging multiple sclerosis
    McKeage, Kate
    CNS DRUGS, 2008, 22 (09) : 787 - 792
  • [22] Dynamics of immune cell trafficking in interferon-β treated multiple sclerosis patients
    Hartrich, L
    Weinstock-Guttman, B
    Hall, D
    Badgett, D
    Baier, M
    Patrick, K
    Feichter, J
    Hong, JM
    Ramanathan, M
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 139 (1-2) : 84 - 92
  • [23] Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-β 1a, and high doses of immunoglobulins
    Sarchielli, P.
    Zaffaroni, M.
    Floridi, A.
    Greco, L.
    Candeliere, A.
    Mattioni, A.
    Tenaglia, S.
    Di Filippo, M.
    Calabresi, P.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (03) : 313 - 331
  • [24] Interferon β-1b inhibits transendothelial migration of monocyte-endothelial microparticle complexes associated with multiple sclerosis
    Jimenez, JJ
    Jy, WC
    Mauro, LM
    Ahn, YS
    Minagar, A
    NEUROLOGY, 2004, 62 (07) : A385 - A385
  • [25] Cytokine profile in interferon-β treated multiple sclerosis patients:: reduction of interleukin-10 mRNA expressing cells in peripheral blood
    Andersson, M
    Khademi, M
    Wallstrom, E
    Olsson, T
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 (06) : 567 - 571
  • [26] Lymphocytes subset composition and modulation of sphingosie-1-phosphate mediated migration in multiple sclerosis patients treated with fingolimod or interferon-β
    Heiko Sic
    Michael Stock
    Sebastian Rauer
    Hermann Eibel
    Journal of Translational Medicine, 10 (Suppl 3)
  • [27] RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b
    Iarlori, C
    Reale, M
    Lugaresi, A
    De Luca, G
    Bonanni, L
    Di Iorio, A
    Feliciani, C
    Conti, P
    Gambi, D
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 107 (01) : 100 - 107
  • [28] Differential immunomodulatory effects of interferon-β1a/1b in patients with multiple sclerosis
    Papachroni, K.
    Fragoulis, N.
    Piperi, C.
    Patrikiou, A.
    Papadimitriou, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 142 - 142
  • [29] Combined treatment of multiple sclerosis patients with cytostatics and interferon-β (1a,1b)
    Daskalovska, V
    Dimova, A
    Bojkovski, V
    Boskova-Petkovska, T
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S262 - S262
  • [30] Luteolin and Interferon-β Modulate Immune Response(s) in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients
    Sternberg, Zohara
    Chadha, Kailash
    Lieberman, Alicia
    Drake, Allison
    Hojnacki, David
    Weinstock-Guttman, Bianca
    Munschauer, Frederick
    ANNALS OF NEUROLOGY, 2009, 66 : S38 - S39
12345